Literature DB >> 24753250

Age-related marrow adipogenesis is linked to increased expression of RANKL.

Sunao Takeshita1, Toshio Fumoto1, Yoshinori Naoe2, Kyoji Ikeda3.   

Abstract

With advancing age bone marrow is progressively replaced with adipose tissue, accompanied by a concomitant decline in bone mass and strength. The mechanism underlying the increase in marrow fat and bone destruction remains elusive. We found that on the way of adipogenic differentiation of marrow stromal cells, receptor activator for NF-κB ligand (Rankl) expression was induced, concomitantly with a down-regulation of osteoprotegerin, which prompted us to hypothesize that cells at a preadipocyte stage express RANKL. This concept was supported by the findings that the early adipogenic transcription factors C/EBPβ and C/EBPδ, but not the late factor peroxisome proliferator-activated receptor γ, bind to the Rankl promoter and stimulate Rankl gene transcription. In fact, when cells isolated from the bone marrow of aging mice were analyzed by flow cytometry, we found that cells expressing the pre-adipocyte marker Pref-1 were RANKL-positive, and the number of these cells was increased with aging, with concomitant down-regulation of osteoprotegerin, and most importantly, that these RANKL(+)/Pref-1(+) marrow cells were capable of generating osteoclasts from bone marrow macrophages. Thus, the capacity of cells at a pre-adipocyte stage to express RANKL via C/EBPβ and C/EBPδ and to support osteoclastogenesis may account partly for the co-progression of fatty marrow and bone destruction with aging.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Adipogenesis; Adipokine; Bone; Osteoclastogenesis; Preadipocyte; RANKL Expression; Steroid Hormone; Transcription Factor

Mesh:

Substances:

Year:  2014        PMID: 24753250      PMCID: PMC4059115          DOI: 10.1074/jbc.M114.547919

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice.

Authors:  Mohammad Shahnazari; Denise Dwyer; Vivian Chu; Frank Asuncion; Marina Stolina; Michael Ominsky; Paul Kostenuik; Bernard Halloran
Journal:  Bone       Date:  2011-11-30       Impact factor: 4.398

3.  Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts.

Authors:  Yuichi Nagase; Mitsuyasu Iwasawa; Toru Akiyama; Yuho Kadono; Masaki Nakamura; Yasushi Oshima; Tetsuro Yasui; Takumi Matsumoto; Jun Hirose; Hiroaki Nakamura; Takeshi Miyamoto; Philippe Bouillet; Kozo Nakamura; Sakae Tanaka
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

4.  Identification and characterization of mouse bone marrow stromal cell lines immortalized by temperature-sensitive SV40 T antigen: supportive activity for osteoclast differentiation.

Authors:  S Takeshita; S Arai; A Kudo
Journal:  Bone       Date:  2001-09       Impact factor: 4.398

5.  Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.

Authors:  M Kanematsu; T Sato; H Takai; K Watanabe; K Ikeda; Y Yamada
Journal:  J Bone Miner Res       Date:  2000-07       Impact factor: 6.741

6.  Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis.

Authors:  J Justesen; K Stenderup; E N Ebbesen; L Mosekilde; T Steiniche; M Kassem
Journal:  Biogerontology       Date:  2001       Impact factor: 4.277

Review 7.  The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis.

Authors:  Monique Bethel; Brahmananda R Chitteti; Edward F Srour; Melissa A Kacena
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

8.  Changes in bone structure and mass with advancing age in the male C57BL/6J mouse.

Authors:  Bernard P Halloran; Virginia L Ferguson; Steven J Simske; Andrew Burghardt; Laura L Venton; Sharmila Majumdar
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

9.  Leptin reduces ovariectomy-induced bone loss in rats.

Authors:  B Burguera; L C Hofbauer; T Thomas; F Gori; G L Evans; S Khosla; B L Riggs; R T Turner
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

10.  Leptin inhibits osteoclast generation.

Authors:  Wayne R Holloway; Fiona McL Collier; Cathy J Aitken; Damian E Myers; Jason M Hodge; Mary Malakellis; Tamara J Gough; Gregory R Collier; Geoffrey C Nicholson
Journal:  J Bone Miner Res       Date:  2002-02       Impact factor: 6.741

View more
  50 in total

Review 1.  The role of osteoclast differentiation and function in skeletal homeostasis.

Authors:  Kyoji Ikeda; Sunao Takeshita
Journal:  J Biochem       Date:  2015-11-03       Impact factor: 3.387

2.  Co-culture with periodontal ligament stem cells enhanced osteoblastic differentiation of MC3T3-E1 cells and osteoclastic differentiation of RAW264.7 cells.

Authors:  Shulan Chen; Xin Ye; Xinbo Yu; Quanchen Xu; Keqing Pan; Shulai Lu; Pishan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Adipogenic niches for melanoma cell colonization and growth in bone marrow.

Authors:  Juan Wang; Guang-Liang Chen; Shan Cao; Ming-Chun Zhao; Yong-Qing Liu; Xiao-Xiang Chen; Cheng Qian
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

4.  Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.

Authors:  Wei Yu; Leilei Zhong; Lutian Yao; Yulong Wei; Tao Gui; Ziqing Li; Hyunsoo Kim; Nicholas Holdreith; Xi Jiang; Wei Tong; Nathaniel Dyment; X Sherry Liu; Shuying Yang; Yongwon Choi; Jaimo Ahn; Ling Qin
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 5.  Bone marrow adipocytes.

Authors:  Mark C Horowitz; Ryan Berry; Brandon Holtrup; Zachary Sebo; Tracy Nelson; Jackie A Fretz; Dieter Lindskog; Jennifer L Kaplan; Gene Ables; Matthew S Rodeheffer; Clifford J Rosen
Journal:  Adipocyte       Date:  2017-08-24       Impact factor: 4.534

Review 6.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

7.  Adipocytes role in the bone marrow niche.

Authors:  Daniel A P Guerra; Ana E Paiva; Isadora F G Sena; Patrick O Azevedo; Miguel Luiz Batista; Akiva Mintz; Alexander Birbrair
Journal:  Cytometry A       Date:  2017-12-13       Impact factor: 4.355

8.  Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.

Authors:  Timothy N Trotter; Justin T Gibson; Tshering Lama Sherpa; Pramod S Gowda; Deniz Peker; Yang Yang
Journal:  Am J Pathol       Date:  2016-09-17       Impact factor: 4.307

Review 9.  A revisionist history of adult marrow stem cell biology or 'they forgot about the discard'.

Authors:  P Quesenberry; L Goldberg
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

10.  The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis.

Authors:  Heather Fairfield; Carolyne Falank; Elizabeth Harris; Victoria Demambro; Michelle McDonald; Jessica A Pettitt; Sindhu T Mohanty; Peter Croucher; Ina Kramer; Michaela Kneissel; Clifford J Rosen; Michaela R Reagan
Journal:  J Cell Physiol       Date:  2017-06-06       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.